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Abstract
Background: Body mass index (BMI) and waist circumference (WC) are used to define cardiovascular and type 2 diabetes
risk. We aimed to derive appropriate BMI and WC obesity cut-off points in a migrant South Asian population.
Methods: 4688 White Europeans and 1333 South Asians resident in the UK aged 40–75 years inclusive were screened for
type 2 diabetes. Principal components analysis was used to derive a glycaemia, lipid, and a blood pressure factor. Regression
models for each factor, adjusted for age and stratified by sex, were used to identify BMI and WC cut-off points in South
Asians that correspond to those defined for White Europeans.
Findings: For South Asian males, derived BMI obesity cut-off points equivalent to 30.0 kg/m2 in White Europeans were
22.6 kg/m2 (95% Confidence Interval (95% CI) 20.7 kg/m2 to 24.5 kg/m2) for the glycaemia factor, 26.0 kg/m2 (95% CI
24.7 kg/m2 to 27.3 kg/m2) for the lipid factor, and 28.4 kg/m2 (95% CI 26.5 kg/m2 to 30.4 kg/m2) for the blood pressure
factor. For WC, derived cut-off points for South Asian males equivalent to 102 cm in White Europeans were 83.8 cm (95% CI
79.3 cm to 88.2 cm) for the glycaemia factor, 91.4 cm (95% CI 86.9 cm to 95.8 cm) for the lipid factor, and 99.3 cm (95% CI
93.3 cm to 105.2 cm) for the blood pressure factor. Lower ethnicity cut-off points were seen for females for both BMI and
WC.
Conclusions: Substantially lower obesity cut-off points are needed in South Asians to detect an equivalent level of
dysglycemia and dyslipidemia as observed in White Europeans. South Asian ethnicity could be considered as a similar level
of risk as obesity (in White Europeans) for the development of type 2 diabetes.
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Introduction
Excess adiposity is a key risk factor for many chronic diseases,
the most prevalent of which are type 2 diabetes and cardiovascular
disease (CVD), collectively called cardiometabolic disease [1], and
is often used to identify high risk groups. Body mass index (BMI),
calculated as weight (kg) divided by height squared (m2), is the
most common method of assessing adiposity in usual health care
practice. Based on epidemiological evidence investigating associ-
ations with mortality and morbidity, BMI cut-off points of 25 kg/m2
and 30 kg/m2 are conventionally used to classify overweight and
obesity respectively [1]. Whilst most of the evidence underpin-
ning these BMI cut-off points originates from White populations,
there is increasing evidence that levels of risk associated with the
classification of overweight and obesity vary across racial groups
[2]. In 2004, an expert consultation by the World Health
Organization (WHO) recommended revised BMI cut-off points
for the classification of overweight (23 kg/m2) and obesity
(27.5 kg/m2) in Asian populations [3]. However, further evidence
suggests that these revised categorisations may still under
represent the risk of cardiometabolic disease in people originating
from India, Pakistan and Bangladesh [4–7]. A recent consensus
statement advised that BMI cut-off points for overweight and
obesity should be lowered to 23 kg/m2 and 25 kg/m2 respec-
tively for Indian Asians [8], this was reiterated by The South
Asian Health Foundation, UK [9]. This has major implications
because health care organisations increasingly advocate the use of
obesity prevention and treatment as a method of reducing the risk
of cardiometabolic disease. There has therefore been a call for
determining obesity thresholds from further scientific evidence in
minority populations [10].
Waist circumference (WC) is another clinically relevant and
increasingly used method of assessing adiposity. Whereas BMI
provides a marker of overall adiposity, WC provides a surrogate
marker of abdominal adiposity, and is the best correlate to visceral
fat mass. Higher levels of WC are strongly associated with risk
factors for, and incidence of, cardiometabolic disease and the
relationships to some outcomes (in particular diabetes in women)
have been shown to be independent of BMI [11–15]. WHO
currently recommends WC cut-off points for identifying those with
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an increased and a substantially increased risk of having or
developing a chronic disease of 80 cm and 88 cm respectively for
women and 94 cm and 102 cm respectively for men of European
extraction [1]. However, as with BMI, population specific cut-off
points for WC are needed. Recent recommendations from expert
groups in the UK and India advise that a WC cut-off point of
80 cm for women and 90 cm for men should be used to identify
obesity in South Asians [8,9]. It has also been suggested that
lifestyle advice should be sought by South Asian women with a
WC greater than 72 cm and South Asian men with a WC greater
than 78 cm [8]. However these latter recommendations are based
on limited data and require further research.
The aim of this paper was to derive appropriate BMI and WC
cut-off points for a migrant South Asian population whereby
classification of obesity are associated with similar levels of
dysglycemia, dyslipidemia and hypertension as those seen in a
White European population.
Methods
Ethical approval
Approval was obtained from the University Hospitals of
Leicester (UHL09320) and Leicestershire Primary Care Research
Alliance (64/2004) local research ethics committees for the
Leicester addition study. No ethical approval was required for
the analysis carried out in this manuscript.
Participants
This study uses baseline data from the Leicester (UK) Addition
study, a population based screening programme. This study has
been described in detail elsewhere [16]. Briefly, 20 local
community practices from Leicester participated in a screening
programme inviting a random sample of people between 40–75
years inclusive (25–75 years for South Asians) to attend a single
session glucose and cardiovascular risk assessment. Those with
known diabetes were excluded. The screening phase ran from
August 2004 to December 2007 and screened 6,749 individuals
from the 30,950 invited (response rate 22%). Written informed
consent was obtained from all participants. Consistent with
national census data, participants were asked to classify themselves
into one of 16 ethnic groups; these included three categories of
White (British, Irish, or other), four categories of Asian or Asian
British (Indian, Pakistani, Bangladeshi, or other) and nine other
categories (4 mixed race categories, Chinese, Chinese other,
Caribbean, African, or any other black background). This study
reports data only from those classifying themselves as White or
Asian, as other groups were too small to provide meaningful data.
Since the South Asian sub groups were predominantly of Indian
origin and also have broadly common ancestry, we combined
them into one ethnic group. In order to limit differences in age
between ethnicities we excluded South Asians younger than 40
years of age (n = 331).
Biochemical, clinical and demographic measurements
Venous blood samples were collected in the morning following an
overnight fast. All individuals underwent a standardised oral glucose
tolerance test [17]. Blood lipids levels, fasting glucose, two hour
glucose, and HbA1c were measured in the same laboratory located
within Leicester Royal Infirmary, UK, using stable methodology
standardised to external quality assurance reference values. Glucose
samples were taken in fluoride oxalate test tubes and placed
immediately in a portable 4 litre 4uC refrigerator (also available on
board the mobile screening unit). HbA1c was analysed by a DCCT
aligned Biorad Variant HPLC II system (Bio-Rad laboratories,
Hemel Hempstead, UK). The imprecision coefficient of variation of
this machinery was ,0.1%, the reference intervals fit with national
recommendations valid for carriers of variant Hb S, C and Q.
Samples were processed within a maximum of two hours, using an
Abbott Aeroset clinical chemistry analyser (Abbott laboratories,
Maidenhead, UK), which employs the hexokinase enzymatic
method. This machinery has an imprecision coefficient of variation
of 1.61%. Serum total cholesterol, high-density lipoprotein (HDL)
cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyc-
erides were measured by means of enzymatic techniques (Dade
Behring Dimension analyser, Newark, USA). Type 2 diabetes was
diagnosed using WHO 1999 criteria [17].
Arterial blood pressure was measured in the sitting position
(Omron Healthcare, Milton Keynes, UK); three measurements
were obtained and the average of the last two measurements was
used. Body weight (Seca UK, Birmingham, UK), WC (midpoint
between the lower costal margin and iliac crest) and height were
also measured to the nearest 0.1 kg and 0.5 cm respectively, by
personnel trained in the ascertainment of these measures.
Statistical analysis
All analyses were carried out using Stata (Version 10.0).
Baseline characteristics for White Europeans and South Asians
male and females were presented as mean (standard deviation) for
continuous variables and count (percentage) for categorical ones.
Differences between White Europeans and South Asians were
calculated using the t-test for continuous data and chi square test
for categorical. The relationship between BMI and WC and each
risk factor of interest was assessed using linear regression, an
interaction term was used to asses ethnicity related differences
between BMI and WC and the risk factors.
Principal components analysis was used to derive a single
summary variable for each measured group of cardiovascular risk
factors. The glycaemia factor combined fasting and 2 hour glucose,
and HbA1c, the lipid factor combined HDL and triglycerides and
the blood pressure factor combined systolic and diastolic blood
pressure. Regression models were fitted with each factor as the
dependent variables separately for males and females, all models
contained BMI, ethnicity and an interaction between BMI and
ethnicity. All models were adjusted for age centred at the mean. The
predicted value for each factor was then calculated for a BMI
30 kg/m2 for White Europeans with mean age. We then
determined the value of BMI which gave the same predicted values
for South Asians to give equivalent cut-off points. 95% confidence
intervals (95% CI) were estimated from the 95% confidence bands
from the predicted values. This process was then repeated using
WC. 102 cm was used to define those at a substantially increased
risk of obesity related complications in White European males, and
88 cm was used for White European females. For each model fitted
the assumptions were assessed: checking the residuals for normality
and homoscedasticity and the linearity of the relationship between
the outcome and the predictors.
Sensitivity analyses were carried out. Firstly we repeated the
modelling excluding those who are taking lipid lowering
medication from the lipid analysis and those who are taking
antihypertensive medication from the blood pressure analysis.
Secondly we excluded HbA1c from the glycaemia factor analysis
as studies have shown ethnic differences for HbA1c that are
independent of fasting and 2 hour glucose measurements [18,19].
Results
Six thousand and forty one participants were included (Table 1).
The South Asians were on average 5.6 years younger than the
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White Europeans (58.6 years versus 53.0 years, p,0.0001), South
Asian males were significantly older than South Asian females
(p = 0.0004), no difference between sexes was found for White
Europeans (p = 0.39). South Asian males had a lower mean BMI
than South Asian females and the White Europeans. South Asians
had higher 2 hour glucose and HbA1c compared to White
Europeans. The prevelence of glucose disorders were higher in the
South Asians, but they have lower rates of dyslipidemia and
hypertension. Statistically significant linear relationships were
found between BMI and WC and all of the risk factors of interest
(fasting glucose, 2 hour glucose, HbA1c, HDL cholesterol,
triglycerides and systolic and diastolic blood pressure). Statistically
significant ethnic differences were seen for the relationships
between BMI with HDL cholesterol and triglycerides and between
WC with 2 hour glucose, systolic blood pressure and HDL
cholesterol (test for BMI*ethnicity and WC*ethnicity interactions
p,0.05) (Tables S1 and S2).
BMI cut-off points
Table 2 shows the equivalent BMI obesity cut-off points for South
Asians compared to White Europeans. For a BMI of 30 kg/m2
in White Europeans cut-off points for South Asian males
were: glycaemia 22.6 kg/m2 (20.7 kg/m2 to 24.5 kg/m2); lipid
26.0 kg/m2 (24.7 kg/m2 to 27.3 kg/m2); blood pressure
28.4 kg/m2 (26.5 kg/m2 to 30.4 kg/m2). Similar obesity cut-off
points were identified for females: glycaemia 21.5 kg/m2
(19.5 kg/m2 to 23.5 kg/m2); lipid 23.9 kg/m2 (22.0 kg/m2 to
25.7 kg/m2); blood pressure 29.1 kg/m2 (24.9 kg/m2 to
33.3 kg/m2). Figures 1 and 2 demonstrate how these cut-off
points were calculated for the glycaemia factor in males and
females. The figures for the lipid and blood pressure factors are
given in the supporting information (Figures S1, S2, S3, S4).
Waist circumference cut-off points
Lower cut-off points were seen for South Asians. South Asian
cut-off points ranged from 83.8 cm (79.3 cm to 88.2 cm) to
99.3 cm (93.5 cm to 105.2 cm) in men and from 69.3 cm
(65.2 cm to 73.4 cm) to 86.6 cm (77.4 cm to 95.8 cm) in women
(Table 3).
Sensitivity analysis and assumptions
Excluding those on antihypertensive (1,479 (24.5%)) or lipid
lowering (719 (11.9%)) medication gave comparable results for
both BMI (Table S3) and WC (Table S4). When excluding HbA1c
Table 1. Baseline characteristics.
South Asian (SA) White European (WE) Total SA vs. WE
Total SA Males Females Total WE Males Females P value
665 688 2209 2479 6041
Age(years) 53.0 (8.7) 53.9 (9.1) 52.2 (8.2) 58.6 (9.5) 58.7 (9.5) 58.5 (9.5) 57.3 (9.6) ,0.0001
BMI (kg/m2) 27.5 (4.9) 26.6 (4.1) 28.4 (5.4) 28.3 (5.0) 28.2 (4.2) 28.4 (5.6) 28.1 (5.0) ,0.0001
,18.5 kg/m2, n (%) 19 (1.4) 12 (1.8) 7 (1.0) 18 (0.4) 1 (0.1) 17 (0.7) 37 (0.6) ,0.0001{
18.5 kg/m2–,25 kg/m2, n (%) 411 (30.4) 225 (33.9) 186 (27.1) 1180 (25.3) 458 (20.9) 722 (29.3) 1591 (26.5)
25 kg/m2–,30 kg/m2, n (%) 571 (42.3) 310 (46.7) 261 (28.0) 2021 (43.4) 1104 (50.4) 917 (37.2) 2592 (42.1)
.= 30 kg/m2, n (%) 350 (25.9) 117 (17.6) 233 (33.9) 1440 (30.9) 628 (28.7) 812 (32.9) 1790 (29.8)
Waist (cm) 92.6 (11.6) 95.8 (10.2) 89.6 (12.2) 94.7 (13.5) 100.0 (11.4) 89.9 (13.4) 94.2 (13.1) ,0.0001
Systolic BP (mmHg) 134.8 (19.1) 138.6 (18.0) 131.2 (19.5) 139.0 (19.4) 141.8 (18.0) 136.4 (20.2) 138.0 (19.4) ,0.0001
Diastolic BP(mmHg) 85.6 (10.8) 86.8 (10.6) 84.4 (10.9) 85.7 (10.5) 87.1 (10.1) 84.4 (10.6) 85.7 (10.5) 0.75
Total cholesterol (mmol/l) 5.2 (1.0) 5.2 (1.0) 5.2 (0.9) 5.7 (1.1) 5.5 (1.1) 5.8 (1.1) 5.6 (1.1) ,0.0001
LDL-cholesterol (mmol/l) 3.3 (0.8) 3.4 (0.9) 3.3 (0.8) 3.6 (0.9) 3.6 (0.9) 3.7 (0.9) 3.6 (0.9) ,0.0001
HDL-cholesterol (mmol/l) 1.2 (0.3) 1.2 (0.3) 1.3 (0.3) 1.4 (0.4) 1.3 (0.3) 1.5 (0.4) 1.4 (0.4) ,0.0001
Triglycerides (mmol/l) 1.4 (0.8) 1.6 (0.9) 1.3 (0.8) 1.4 (0.9) 1.6 (1.1) 1.3 (0.7) 1.4 (0.9) 0.73
Fasting glucose (mmol/l) 5.3 (0.9) 5.4 (0.9) 5.1 (0.8) 5.2 (0.9) 5.3 (1.1) 5.1 (0.8) 5.2 (0.9) 0.002
2 hour glucose (mmol/l) 6.5 (2.7) 6.5 (2.8) 6.4 (2.5) 5.9 (2.4) 5.8 (2.6) 5.9 (2.2) 6.0 (2.5) ,0.0001
HbA1c (%) 5.9 (0.6) 5.9 (0.7) 5.8 (0.6) 5.7 (0.6) 5.7 (0.7) 5.6 (0.5) 5.7 (0.6) ,0.0001
Type 2 Diabetes, n (%) 68 (5.1) 40 (6.1) 28 (4.1) 128 (2.7) 75 (3.4) 53 (2.2) 196 (3.3) ,0.0001
IGT, n (%) 198 (14.7) 100 (15.2) 98 (14.3) 505 (10.8) 224 (10.2) 281 (11.4) 703 (11.7) ,0.0001
IFG, n (%) 69 (5.1) 43 (6.5) 26 (3.8) 206 (4.4) 114 (5.2) 92 (3.7) 275 (4.6) 0.27
Hypertension, n (%) 604 (45.1) 329 (50.0) 275 (40.3) 2390 (51.8) 1252 (57.4) 1138 (46.8) 2994 (50.3) ,0.0001
Dyslipidemia, n (%) 792 (59.2) 390 (59.4) 402 (59.1) 3418 (73.6) 1508 (68.9) 1910 (77.9) 4210 (70.4) ,0.0001
Antihypertensive therapy, n (%) 297 (22.0) 162 (24.4) 135 (19.6) 1182 (25.2) 572 (25.9) 610 (24.6) 1479 (24.5) 0.01
Lipid lowering therapy, n (%) 143 (10.6) 95 (14.3) 48 (7.0) 576 (12.3) 328 (14.9) 248 (10.0) 719 (11.9) 0.09
Data given as mean (standard deviation) unless stated. Comparison of South Asians and White Europeans is made using t-test for continuous variables and the chi
square test for categorical.
IGT: Impaired glucose tolerance, IFG: Impaired fasting glucose, hypertension defined as systolic .= 140 mmHg or diastolic .=90 mmHg, dyslipidemia defined as total
cholesterol .= 5.0 mmol/l,
{Chi square test compares 4 BMI groups by ethnicity.
doi:10.1371/journal.pone.0026464.t001
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from the glycaemia factor, slightly higher cut-off points were seen
for both BMI and WC for males and females (Tables S5 and S6).
The statistical assumptions were satisfied for all of the models
fitted.
Discussion
Using data from a large diabetes screening study, we used
principal components analysis to combine multiple cardiometa-
bolic risk markers into single glycaemia, lipid, and blood pressure
factors. For example, the derived glycaemia factor, calculated
obesity cut-off points for South Asian were 22.6 kg/m2 for males
and 21.5 kg/m2 for females. WC cut-off points were also
substantially lower in South Asians than those currently recom-
mended [1].
It has consistently been shown that the prevalence of many
chronic diseases in developed countries is substantially higher in
South Asian populations, for example the risk of type 2 diabetes is
between 2 and 6 times higher in South Asians compared to White
Europeans [20–22]. However there has been little attempt to
investigate whether ethnic differences exist in the association
between levels of adiposity and cardiometabolic risk. To our
knowledge, only one other modest study (n = 590) has directly
compared BMI cut-off points for obesity between migrant South
Asians and White Europeans [4]. Using similar methodology as
applied here, they reported BMI cut-off points for obesity of
between 21.1 kg/m2 and 22.5 kg/m2 in South Asians [4]. Studies
using receiver operating characteristic curves methodology for
identifying optimal BMI cut-off points for discriminating between
those with and without type 2 diabetes or the metabolic syndrome
have shown cut-off points between 22 kg/m2 and 23 kg/m2
[5,6,23]. While a cut-off point of 21 kg/m2 has been reported to
be optimal for identifying the presence of at least one CVD risk
factor [7]. It has also been suggested that ethnic specific cut-off
points may vary by country [24]. In contrast a Canadian study
found that cut-off points should be lowered for East Asians but
not for South Asians, however this study was carried out on a
limited sample (n = 357) [25]. A recent large study (n = 7729)
looking at cut-off points for WC only for White Europeans and
South Asians also concurred that lower cut-off points are needed
Table 2. White European equivalent cut-off point for South Asians for a BMI of 30 kg/m2.
Males Females
Glycaemia factor 22.6 kg/m2 (20.7 kg/m2 to 24.5 kg/m2) 21.5 kg/m2 (19.5 kg/m2 to 23.5 kg/m2)
Lipid factor 26>0 kg/m2 (24.7 kg/m2 to 27.3 kg/m2) 23.9 kg/m2 (22.0 kg/m2 to 25.7 kg/m2)
Blood pressure factor 28.4 kg/m2 (26.5 kg/m2 to 30.4 kg/m2) 29.1 kg/m2 (24.9 kg/m2 to 33.3 kg/m2)
Factor is the single summary variable derived from the principal components analysis. Glycaemia factor includes fasting glucose, 2 hour glucose and HbA1c; Lipid factor
includes HDL cholesterol and triglycerides; Blood pressure factor includes systolic and diastolic blood pressure.
doi:10.1371/journal.pone.0026464.t002
Figure 1. Relationship between glycaemia factor and BMI among White European and South Asian males. The glycaemia factor is the
single summary variable derived from the principal components analysis using fasting glucose, 2 hour glucose and HbA1c.
doi:10.1371/journal.pone.0026464.g001
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to define equivalent levels of diabetes risk [26]. The use of
principal components analysis to combine multiple risk markers
into a single factor has several advantages over other methods,
such as receiver operating characteristic curves or logistic
regression, these have been described in detail elsewhere [4].
No other studies have derived both BMI and WC cut-off points
using this methodology on a large bi ethnic population based UK
data set.
These results highlight the fact that South Asians face the
double burden of dysglycemia and dyslipidemia at substantially
lower levels of adiposity than White Europeans; this has some
important implications. In order to ensure equivalence in targeting
at risk individuals, BMI and WC cut-off points need to be
substantially lower in South Asian populations than those
currently recommended by WHO. Indeed, for most of the factors
considered, the majority of the South Asian population in
developed countries have a BMI over the obesity BMI cut-points
suggested here. For example, the majority of South Asian
participants in this population based study of 40–75 year olds
had a BMI of over 25 kg/m2. Therefore, the vast majority of
South Asians will have a higher risk of cardiometabolic disease,
particularly type 2 diabetes, than a White European with a BMI of
30 kg/m2. Consequently South Asian ethnicity per se should be
viewed as denoting a similar level of risk as obesity does in White
Europeans.
This data should not be used to infer that South Asians with a
BMI of less than 22.6 kg/m2, have excess adiposity and hence
require weight loss intervention; however it does suggest that in
addition to traditional obesity management initiatives, other
prevention strategies and educational messages urgently need to
Table 3. White European equivalent waist circumference (cm) cut-off points for South Asians.
Males Females
(White European =102 cm) (White European =88 cm)
Glycaemia factor 83.8 cm (79.3 cm to 88.2 cm) 69.3 cm (65.2 cm to 73.4 cm)
Lipid factor 91>4 cm (86.9 cm to 95.8 cm) 74.2 cm (69.3 cm to 79.0 cm)
Blood pressure factor 99.3 cm (93.3 cm to 105.2 cm) 86.6 cm (77.4 cm to 95.8 cm)
Factor is the single summary variable derived from the principal components analysis. Glycaemia factor includes fasting glucose, 2 hour glucose and HbA1c; Lipid factor
includes HDL cholesterol and triglycerides; Blood pressure factor includes systolic and diastolic blood pressure.
doi:10.1371/journal.pone.0026464.t003
Figure 2. Relationship between glycaemia factor and BMI amongWhite European and South Asian females. The glycaemia factor is the
single summary variable derived from the principal components analysis using fasting glucose, 2 hour glucose and HbA1c.
doi:10.1371/journal.pone.0026464.g002
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be developed, evaluated and promoted in this population. For
example, South Asians have consistently been found to be
substantially less physically active than White European popula-
tions in industrialised countries [27] and intervention studies
aimed at the promotion of physical activity have been shown to be
effective at targeting/attenuating cardiometabolic risk factors
across many different population groups, including South Asians
[28]. However, examples of multifactorial health behaviour
interventions that have been developed and evaluated in migrant
South Asian populations are lacking.
This study did not observe differences between South Asians
and White Europeans in the distribution of blood pressure across
levels of BMI or WC. This finding confirms other smaller studies
in multi ethnic populations and suggests that hypertension per se
does not appear to contribute to the increased risk of
cardiometabolic disease observed in South Asians over White
Europeans [4,29].
Study limitations
Although this is the largest study to date to derive cut-off points
for migrant South Asians using robust methodology, there are
some limitations which need to be taken into account when
interpreting the data. Firstly, the cross sectional design limited
our analysis to risk factors for, rather than the incidence of,
chronic disease. Whilst it is clear that elevated levels of glycaemia
and lipids are key risk factors for type 2 diabetes and CVD, our
analysis assumed that these risk markers are equally predictive of
future chronic disease across ethnicities. Whilst there are little
published data to confirm or reject this assumption, evidence
from a subset of participants included in the present study found
that South Asians with impaired glucose tolerance and/or
impaired fasting glucose were almost 3 times more likely to
progress to type 2 diabetes than White Europeans with the same
diagnosis over a 12 month period [30], consistent with a greater
metabolic susceptibility to weight gain. This suggests that the
calculated South Asian BMI cut-off points for obesity derived
from the glycaemia factor were in fact a conservative interpre-
tation of the data. Secondly, 22% of those invited came forward
for screening; this is similar to, or higher than, other studies in
similar populations [31] and reflects the difficulty in recruiting a
multi-ethnic urban population with wide variations in social
economic status into clinical trials. Additionally, those screened
were slightly older than those invited [32]. Furthermore, the
difference in sample size between the South Asian and White
European cohorts (1,353 and 4,688 respectively) and the
differences seen between these groups in terms of their risk
profile may impact the power of this analysis. We recognise that
although these limitations may compromise the representative-
ness of the sample, the large size of the cohort and the high
quality of the collected data increase the credibility of our
findings. Thirdly, ethnicity was recorded by asking the partici-
pants to classify themselves into one of 16 ethnic groups. Ancestry
was not considered in this classification. In deriving the cut-off
points we were not able to take into account environmental
factors such as nutrition which may be important, especially in a
migrant population. Therefore the results should not be
generalized to all South Asian populations. Finally the derived
factors for glycaemia, lipids and blood pressure should only be
interpreted as crude summaries of these components. They do
not include all possible variables which could be related to these
factors, but rather those that were related to BMI and WC. As
seen in the previous study using this methodology, not all of the
variation was explained by the variables included in the three
factors [4].
Summary
Substantially lower obesity cut-off points are needed in South
Asians to detect an equivalent level of dysglycemia in particular
and dyslipidemia as observed in White Europeans. As the majority
of South Asians have a BMI above the obesity cut-off point
derived from the glycaemia factor, South Asian ethnicity per se
could be viewed as conferring a similar level of risk for developing
type 2 diabetes as obesity does in White Europeans. Twenty
percent of the total world population is of South Asian ethnicity
and therefore it is important that South Asians are offered the
same treatment at an equivalent level of risk to other ethnicities.
Our data also suggest a need to strongly reiterate that South
Asians have an even greater need to maintain a healthy weight
than the European Whites.
Supporting Information
Figure S1 Relationship between lipid factor and BMI among
White European and South Asian males. The lipid factor is the
single summary variable derived from the principal components
analysis using HDL cholesterol and triglycerides.
(TIF)
Figure S2 Relationship between lipid factor and BMI among
White European and South Asian females. The lipid factor is the
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